|
|
|
| Clinical effect of Qingshen Guanchang Fluid on chronic renal failure |
| YANG Yuanyuan LIU Shifu LYU Wei |
| Department of Nephrology, Wuhu Hospital of Traditional Chinese Medicine, Anhui Province, Wuhu 241000, China |
|
|
|
Abstract Objective To study the clinical efficacy of Qingshen Guanchang Fluid in the treatment of chronic renal failure. Methods A total of 66 patients with chronic renal failure admitted to Department of Nephrology, Wuhu Hospital of Traditional Chinese Medicine from January 2018 to January 2021 were selected as the research objects. They were divided into the control group and the observation group according to the random number table method, with 33 cases in each group. The control group was treated with basic therapy, while the observation group was treated with Qingshen Guanchang Fluid on the basis of the control group. Traditional Chinese medicine symptom scores, renal function indexes, laboratory related indexes, clinical efficacy and adverse reactions were compared between the two groups. Results After treatment, the scores of traditional Chinese medicine symptoms in the two groups were lower than those before treatment, and that in the observation group was lower than that in the control group (P < 0.01). After treatment, the levels of serum creatinine, urea nitrogen, uric acid, and cystatin C in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P < 0.05). After treatment, the levels of serum calcium, phosphorus, and potassium in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P < 0.05). After treatment, the clinical effect of the observation group was better than that of the control group (P < 0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P > 0.05). Conclusion Qingshen Guanchang Fluid is safe and effective in the treatment of chronic renal failure.
|
|
|
|
|
|
[1] 余怡，常美莹，王如梦，等.张昱教授运用加味大补元煎治疗慢性肾衰竭的经验[J].中国医药导报，2021，18（19）：138-141.
[2] 白兰，张燕，刘鹏霄，等.中医药对慢性肾衰竭患者微炎症状态影响的研究现状[J].西部中医药，2021，34（9）：150-153.
[3] 朱凌波，罗燕萍.肾衰合剂联合中药灌肠治疗早中期慢性肾衰竭临床观察[J].交通医学，2020，34（6）：603-605.
[4] 王海燕.肾脏病学[M].北京：人民卫生出版社，2008：1815-1816.
[5] 郑筱萸.中药新药临床研究指导原则（试行）M].北京：中国医药科技出版社，2002：247-248.
[6] Lowe M，Jervis S，Payton A，et al. Systematic review of associations between HLA and renal function [J]. Int J Immunogenet，2022，49（1）：46-62.
[7] Hahn J，Virk HUH，Al-Azzam F，et al. Outcomes of transcatheter aortic valve implantation in patients with chronic and end-stage kidney disease [J]. Am J Cardiol，2022， 164：100-102.
[8] 刘施，高越，陈树和.基于中医传承辅助平台挖掘巴元明教授治疗慢性肾衰竭方药规律[J].中国医药导报，2020， 17（7）：135-138.
[9] 盛晓茜.健脾益肾方治疗慢性肾衰竭早期临床疗效观察[J].辽宁中医药大学学报，2021，23（11）：128-132.
[10] 吴力强.益肾活血降浊汤对慢性肾衰竭患者肾功能及钙磷代谢的影响[J].内蒙古中医药，2021，40（11）：22-23.
[11] 唐荣，张帆.腹膜透析液保留灌肠治疗慢性肾衰竭的疗效观察[J].国际泌尿系统杂志，2017，37（1）：16-18.
[12] 朱俊.基于数据挖掘王钢教授辨治慢性肾衰竭临床经验研究[D].南京：南京中医药大学，2021.
[13] 李淑菊，田锋，杨菲菲.基于数据平台挖掘分析国医大师张琪治疗慢性肾衰竭的用药规律[J].中医药学报，2020， 48（10）：32-38.
[14] 童赟，林泽文，黄霞.不同时辰中药保留灌肠对慢性肾衰竭患者的影响[J].中华现代护理杂志，2014，20（32）：4092-4095.
[15] 徐丽.基于中医传承辅助平台系统探析王丹教授治疗慢性肾衰竭的用药规律[D].哈尔滨：黑龙江中医药大学，2020.
[16] 张上鹏，陈国伟，吴禹池，等.林启展教授从脾肾论治慢性肾衰竭经验介绍[J].中国中西医结合肾病杂志，2018， 19（4）：343-344.
[17] 姚硕硕，魏晓娜，籍大为，等.基于国医大师李佃贵“浊毒理论”治疗慢性肾衰竭的应用研究[J].陕西中医，2019， 40（4）：519-521.
[18] 范为民，李艳.国医大师李济仁教授辨治肾系疾病经验撷要[J].时珍国医国药，2016，27（12）：3027-3029.
[19] 赵大鹏，刘一灵，薛晓颖，等.论大黄在慢性肾衰竭中应用[J].辽宁中医药大学学报，2022，24（1）：13-17.
[20] 娜迪热·迪力夏提，迪丽努尔·吐尔洪.中药灌肠疗法治疗慢性肾衰竭研究现状[J].新疆中医药，2020，38（5）：103-106.
[21] 王琦.益肾泄浊化瘀通络方灌肠治疗慢性肾衰竭早中期的临床观察[D].张家口：河北北方学院，2021.
[22] 李倩，郝丽，周革霞，等.改良式结肠透析联合中药保留灌肠治疗慢性肾衰竭的临床研究[J].河北中医，2020， 42（9）：1337-1340，1384.
[23] 潘金欣，陈霞，崔莹莹，等.中药灌肠联合血液透析对慢性肾衰竭患者炎症介质水平及肾功能的影响[J].实用中西医结合临床，2021，21（12）：22-23，95.
[24] 邹丽华，张香卉.慢肾安灌肠液治疗慢性肾功能衰竭70例临床观察[J].中国中医基础医学杂志，2016，22（9）：1275-1276.
[25] 刘垠浩，陈丽贞.肾衰汤联合灌肠方治疗慢性肾衰竭临床观察[J].福建中医药，2021，52（7）：10-14. |
|
|
|
